3. Bipolar I
At least one manic episode,
usually accompanied by a
major depressive episode.
Bipolar II
Characterized by one or more
major depressive episodes
accompanied by at least one
hypomanic episode.
4. DDiiffffeerreennttiiaall DDiiaaggnnoosseess
MDD
• Just depressive episodes
• If there is a hx of at least one manic or hypomanic episode =
BP
Cyclothymic Disorder
• experience of numerous episodes of hypomanic and
depressive symptoms that don’t meet criteria for MDD
• possibility of developing bipolar disorder
5. Bipolar in Children
Non-episodic, chronic, rapid-cycling mixed state
featuring agitation, excitability, labile affect, aggression,
and irritability with child’s age-appropriate functioning
significantly impaired
Frequent comorbidity with ADHD & CD
Disruptive mood dysregulation disorder (DSM V)
6. Comorbidity
Suicide: 10-15%
School truancy, school failure,
occupational failure, divorce
Other diagnoses
• Eating Disorders
• ADHD
• Anxiety Disorders
• Substance-Related Disorders (60% risk)
Borderline Personality Disorder
Medical disorders
7. Etiology:
biological factors predominate
First-degree relatives elevated rates of Bipolar I Disorder (4-24%),
Bipolar II Disorder (1-5%), and MDD (4-24%)
Twin and adoption studies - evidence of genetic influence
Polygenic models promising but core of BPD remains elusive
Limbic system
Amount of norepinephrine, serotonin, gamma-aminobutyric acid
neurotransmitters are abnormal
Actions of thyroid and other endocrine glands also account for nervous
system changes
Biorythms (body’s natural sleep and wake cycles) are erratic - may cause
or result from chemical imbalances
Damage to areas in brain responsible for emotional activity
8. OtherC Roisukr sFeactors
Stressful life events (onset and course)
Early onset
10% rapid cycling
Families with high EE
Lack of social support
Number of previous episodes
History of anxiety
Persistence of affective symptoms even
when mood is relatively stable
Poor occupational functioning
9. Medication
Mood-stabilizing meds sometimes prescribed with
antipsychotic meds to treat BP I
Antidepressants - BP II
10. Lithium Carbonate
Improvements in 70% of clients
Relatively short half life - must be taken more than once
per day
Takes 2-3 weeks to establish effect
Doesn’t preclude possibility of recurrence
• 36% recurrence rate in 5 yrs.
• Combinations (with antidepressant, antipsychotic, &
anticonvulsant drugs) may help
Lithium prescribed for 1 year after first or second
episode, permanent after third episode
11. Importance of
Monitoring Blood
Levels
Difference between therapeutic and
toxic levels is not so great
Monitoring monthly for 1st 4-6
months, every 6 mos. after that
Symptoms: thirst, weight gain,
fatigue, hand tremor, muscle
weakness, confusion, diarrhea,
dizziness, nausea, slurred speech,
spastic muscle movements
12. Anticonvulsants:
Carbamazephine
Blocks norepinephrine reuptake, may also break
down GABA
Advantages over lithium
• stabilize mood in 2-5 days
• as effective for stabilizing
• more effective for maintenance
• has a greater antidepressant effect
Side effects problematic - 50% not taking a year later
13. Anticonvulsants, cont.:
Valproate
Comparable to lithium
May be better than carbamazepine for rapid cycling
Trend toward prescribing anticonvulsants as initial
tx strategy
14. Medication Used with
Children
Lithium, carbamazepine,
and valproate all used
with children
Prospects of chronic
weight problems and
long-term effects on
kidney function need to
be considered
15. Psychoeducation
Coming to terms
• Reduce medication non-adherence
• Enhance social and
occupational functioning
• Enhance family and social
support
• Identify stresses that may
trigger mood episodes
16. Individual
Psychotherapy
Interpersonal therapy
• interpersonal conflicts major source of
depression
• also assumes sleep/wake cycle and social
rhythms influence course
CBT
• challenge cognitions that may activate
episodes and be related to medication
compliance